Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/xsxA2UQQtc Published simultaneously with the LOOP study presented at #ESCCongress - follow thread for discussion
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2021 – Jan 2024Where it's discussed
-
X / Twitter63 posts
-
News40 articles
-
Blogs5 articles
-
Facebook4 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions highlight specific concepts from the study, with users mentioning the benefits of screening older adults for atrial fibrillation. Comments like 'screen worthy condition' and references to the 'transformative potential' of the findings illustrate an enthusiastic tone, showcasing a collective acknowledgment of the study's insight and relevance.
Most discussions reflect strong support for the findings of the trial, emphasizing the benefits of screening for atrial fibrillation.
Participants express high curiosity, engaging deeply with the implications of the research.
Many posts engage with specific details of the study and its methodology, indicating a robust level of discussion.
There is a consensus that the publication could significantly influence clinical practices regarding atrial fibrillation screening.
Abstract in brief
- The STROKESTOP trial aimed to determine if systematic screening for atrial fibrillation in older adults could reduce deaths and strokes compared to no screening.
- Conducted in Sweden, the study randomly assigned nearly 14,400 individuals to either receive screening or serve as a control, following them for an average of 6.9 years.
- Results showed that participants who were screened experienced significantly fewer primary adverse events, such as strokes and deaths, than those in the control group.
Top posts
Most liked on X and BlueskyEn nuestra primera sesión
#Kardiologie #Lipidologie
@HeerspinkHiddo @DavidCWheeler2 @EWijkmark @MagnusAstrand @GreaserPete @BradRovin @IgAN_JBarratt @Dan_Fuster @inselgruppe @unibern @sadrijacukoski @weimbslab @MuellerRom 1: CONVINCE from @Peterblankesti2 and others @ConvinceStudy Thanks for your large participation during our streaming! We wish you all a merry Christmas, and we will back with Best of Cardiology - with @StephanSchirme1 @floriancustodis and @JaninePoss https://t.co/vTo592KNWc
14日間の断続的な心電図で心房細動が発見されたら経口抗凝固薬で治療するスクリーニングを行うと,6~9年後の主要複合エンドポイントである虚血性または出血性の脳卒中,全身性塞栓症,入院を伴う出血,および全死亡がHR 0.96(95%CI 0.92~1.00)に僅かに減少した. https://t.co/yxGfzl75R8
@Dominik_Linz @drjohnm @Moscoso_Costa @rbcasado @J_Hendriks1 @DrAfzalSohaib @DavidDuncker @Rhythmisit @PrashSanders Thanks - You can find the STROKESTOP study online here: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/Xr21zYvL4Z
All mentions
Kardiologie / Lipidologie 2023 - Priv.-Doz. Dr. Janine Pöss und das MARKUS @ HOMe Editorenteam
Cardiac Rhythm Monitoring for Atrial Fibrillation Management
This Harvard Medical School video examines the role of cardiac rhythm monitoring in detecting and managing atrial fibrillation (AF). It reviews implantable and wearable telemonitoring technologies, their pros and cons…
RT @floriancustodis: #Kardiologie #Lipidologie
RT @floriancustodis: #Kardiologie #Lipidologie
RT @floriancustodis: #Kardiologie #Lipidologie
RT @floriancustodis: #Kardiologie #Lipidologie
RT @floriancustodis: #Kardiologie #Lipidologie
#Kardiologie #Lipidologie
RT @gunnar_heine: @HeerspinkHiddo @DavidCWheeler2 @EWijkmark @MagnusAstrand @GreaserPete @BradRovin @IgAN_JBarratt @Dan_Fuster @inselgruppe…
RT @gunnar_heine: @HeerspinkHiddo @DavidCWheeler2 @EWijkmark @MagnusAstrand @GreaserPete @BradRovin @IgAN_JBarratt @Dan_Fuster @inselgruppe…
@HeerspinkHiddo @DavidCWheeler2 @EWijkmark @MagnusAstrand @GreaserPete @BradRovin @IgAN_JBarratt @Dan_Fuster @inselgruppe @unibern @sadrijacukoski @weimbslab @MuellerRom 1: CONVINCE from @Peterblankesti2 and others @ConvinceStudy Thanks for your large participation during our streaming! We wish you all a merry Christmas, and we will back with Best of Cardiology - with @StephanSchirme1 @floriancustodis and @JaninePoss https://t.co/vTo592KNWc
この取り組みは、ファーストアクセスの場としてよさそうか気がしますね。 あと24軒の薬局で…と読んでしまいましたがミスリードでした。 こういう論文結果もありますし https://t.co/I3BJ0Aj63t https://t.co/ZvYTlWltQD
RCT/無症状の75歳に心房細動のスクリーニングを行い、診断された場合は抗凝固療法を開始することにより、虚血性および出血性脳卒中、全身の塞栓症、入院が必要な出血、すべての死亡の複合アウトカムを改善させたが、個別のアウトカムでは差がなかった(STROKESTOP) https://t.co/1OggsgdPMN
@mgtmccartney @dr_benoy_n_shah @pash22 @drjohnm @ShariqShamimMD @AFPJournal @AndrewFoy82 Svennberg E, Friberg L, Frykman V, Al-Khalili F, Engdahl J, Rosenqvist M. Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet. 2021 Oct 23;398(10310):1498-1506.
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/sGyLYGWVzh
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unma… https://t.co/DOn2lCl8JM
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial - The Lancet https://t.co/JSrASQDrwA
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/fzh3Wj6XrA
Parece que el cribado de la fibrilación auricular mediante EKG en pacientes de 75-76 años es beneficioso. ' Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/eM67SZ1RZj
RT @FormigaFrancesc: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmaske…
RT @JournalClubMS: En nuestra primera sesión
RT @FormigaFrancesc: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmaske…
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/P08rPJRUPe @mi_cardiologo @JCosinSales @chemachir @Medtorek @IcyfaSemi @mendez_bailon @ana_apiecar @GullonAlejandra
RT @JournalClubMS: En nuestra primera sesión
RT @JournalClubMS: En nuestra primera sesión
RT @JournalClubMS: En nuestra primera sesión
RT @JournalClubMS: En nuestra primera sesión
RT @JournalClubMS: En nuestra primera sesión
RT @JournalClubMS: En nuestra primera sesión
RT @JournalClubMS: En nuestra primera sesión
RT @JournalClubMS: En nuestra primera sesión
RT @JournalClubMS: En nuestra primera sesión
RT @JournalClubMS: En nuestra primera sesión
En nuestra primera sesión
心房細動のスクリーニングは高齢者において安全で有益であるかもしれない https://t.co/vRxPgKJWa3
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial - PubMed https://t.co/fEyshxWrmd
RT @upshur_ross: Happy to see this study published, have argued that Afib in older adults is a "screen worthy" condition Clinical outcomes…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @upshur_ross: Happy to see this study published, have argued that Afib in older adults is a "screen worthy" condition Clinical outcomes…
Happy to see this study published, have argued that Afib in older adults is a "screen worthy" condition Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/ilGYLWyeeE
RT @GiusepeBellelli: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmaske…
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/O2q8zppckf
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial - https://t.co/J82RcdQctR
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial - https://t.co/WV1wRY0QIr
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/ymaVEfphxp
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
14日間の断続的な心電図で心房細動が発見されたら経口抗凝固薬で治療するスクリーニングを行うと,6~9年後の主要複合エンドポイントである虚血性または出血性の脳卒中,全身性塞栓症,入院を伴う出血,および全死亡がHR 0.96(95%CI 0.92~1.00)に僅かに減少した. https://t.co/yxGfzl75R8
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: @Dominik_Linz @drjohnm @Moscoso_Costa @rbcasado @J_Hendriks1 @DrAfzalSohaib @DavidDuncker @Rhythmisit @PrashSanders Than…
RT @EmmaSvennberg: @Dominik_Linz @drjohnm @Moscoso_Costa @rbcasado @J_Hendriks1 @DrAfzalSohaib @DavidDuncker @Rhythmisit @PrashSanders Than…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked,…
RT @EmmaSvennberg: @Dominik_Linz @drjohnm @Moscoso_Costa @rbcasado @J_Hendriks1 @DrAfzalSohaib @DavidDuncker @Rhythmisit @PrashSanders Than…
@Dominik_Linz @drjohnm @Moscoso_Costa @rbcasado @J_Hendriks1 @DrAfzalSohaib @DavidDuncker @Rhythmisit @PrashSanders Thanks - You can find the STROKESTOP study online here: Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/Xr21zYvL4Z
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/xsxA2UQQtc Published simultaneously with the LOOP study presented at #ESCCongress - follow thread for discussion
Find them in here @TheLancet DOI:https://t.co/OMR8YiqMEw DOI:https://t.co/BIV1LoWd7y https://t.co/SDUKsEZpYb
[Articles] Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial https://t.co/xsZLFCAgyY